Logo image of ACKB.BR

ACKERMANS & VAN HAAREN (ACKB.BR) Stock Fundamental Analysis

EBR:ACKB - Euronext Brussels - BE0003764785 - Common Stock - Currency: EUR

220.2  +2.2 (+1.01%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ACKB. ACKB was compared to 48 industry peers in the Construction & Engineering industry. There are concerns on the financial health of ACKB while its profitability can be described as average. ACKB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ACKB was profitable.
In the past year ACKB had a positive cash flow from operations.
Each year in the past 5 years ACKB has been profitable.
ACKB had a positive operating cash flow in each of the past 5 years.
ACKB.BR Yearly Net Income VS EBIT VS OCF VS FCFACKB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of ACKB (2.27%) is comparable to the rest of the industry.
The Return On Equity of ACKB (8.71%) is worse than 64.58% of its industry peers.
ACKB has a worse Return On Invested Capital (4.79%) than 68.75% of its industry peers.
ACKB had an Average Return On Invested Capital over the past 3 years of 3.75%. This is significantly below the industry average of 10.61%.
The last Return On Invested Capital (4.79%) for ACKB is above the 3 year average (3.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.27%
ROE 8.71%
ROIC 4.79%
ROA(3y)2.79%
ROA(5y)2.43%
ROE(3y)10.71%
ROE(5y)9.77%
ROIC(3y)3.75%
ROIC(5y)3.25%
ACKB.BR Yearly ROA, ROE, ROICACKB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of ACKB (7.61%) is better than 72.92% of its industry peers.
ACKB's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 9.41%, ACKB is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
In the last couple of years the Operating Margin of ACKB has grown nicely.
The Gross Margin of ACKB (37.01%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ACKB has remained more or less at the same level.
Industry RankSector Rank
OM 9.41%
PM (TTM) 7.61%
GM 37.01%
OM growth 3Y6.69%
OM growth 5Y4.48%
PM growth 3Y-6.91%
PM growth 5Y-3.82%
GM growth 3Y0.27%
GM growth 5Y1.41%
ACKB.BR Yearly Profit, Operating, Gross MarginsACKB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

ACKB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ACKB has about the same amount of shares outstanding.
ACKB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, ACKB has an improved debt to assets ratio.
ACKB.BR Yearly Shares OutstandingACKB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACKB.BR Yearly Total Debt VS Total AssetsACKB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

ACKB has an Altman-Z score of 0.88. This is a bad value and indicates that ACKB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACKB (0.88) is worse than 89.58% of its industry peers.
The Debt to FCF ratio of ACKB is 9.05, which is on the high side as it means it would take ACKB, 9.05 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 9.05, ACKB is in line with its industry, outperforming 45.83% of the companies in the same industry.
ACKB has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
ACKB's Debt to Equity ratio of 0.49 is in line compared to the rest of the industry. ACKB outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.05
Altman-Z 0.88
ROIC/WACC1.17
WACC4.08%
ACKB.BR Yearly LT Debt VS Equity VS FCFACKB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

ACKB has a Current Ratio of 0.74. This is a bad value and indicates that ACKB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.74, ACKB is doing worse than 89.58% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that ACKB may have some problems paying its short term obligations.
The Quick ratio of ACKB (0.70) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.7
ACKB.BR Yearly Current Assets VS Current LiabilitesACKB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.83% over the past year.
ACKB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.40% yearly.
Looking at the last year, ACKB shows a quite strong growth in Revenue. The Revenue has grown by 15.74% in the last year.
ACKB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.19% yearly.
EPS 1Y (TTM)15.83%
EPS 3Y4.64%
EPS 5Y3.4%
EPS Q2Q%13.71%
Revenue 1Y (TTM)15.74%
Revenue growth 3Y11.91%
Revenue growth 5Y7.19%
Sales Q2Q%13.03%

3.2 Future

The Earnings Per Share is expected to grow by 6.14% on average over the next years.
The Revenue is expected to grow by 0.35% on average over the next years.
EPS Next Y25.08%
EPS Next 2Y8.03%
EPS Next 3Y6.14%
EPS Next 5YN/A
Revenue Next Year3.92%
Revenue Next 2Y2%
Revenue Next 3Y0.35%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACKB.BR Yearly Revenue VS EstimatesACKB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
ACKB.BR Yearly EPS VS EstimatesACKB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.67, ACKB is valued correctly.
ACKB's Price/Earnings is on the same level as the industry average.
ACKB is valuated rather cheaply when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.97, which indicates a very decent valuation of ACKB.
64.58% of the companies in the same industry are more expensive than ACKB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 35.28. ACKB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 15.67
Fwd PE 11.97
ACKB.BR Price Earnings VS Forward Price EarningsACKB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

ACKB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ACKB is more expensive than 66.67% of the companies in the same industry.
ACKB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ACKB is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.64
EV/EBITDA 14.37
ACKB.BR Per share dataACKB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

ACKB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.62
PEG (5Y)4.6
EPS Next 2Y8.03%
EPS Next 3Y6.14%

4

5. Dividend

5.1 Amount

ACKB has a Yearly Dividend Yield of 1.23%.
ACKB's Dividend Yield is comparable with the industry average which is at 4.21.
With a Dividend Yield of 1.23, ACKB pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

The dividend of ACKB is nicely growing with an annual growth rate of 7.81%!
Dividend Growth(5Y)7.81%
Div Incr Years5
Div Non Decr Years6
ACKB.BR Yearly Dividends per shareACKB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

24.20% of the earnings are spent on dividend by ACKB. This is a low number and sustainable payout ratio.
ACKB's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.2%
EPS Next 2Y8.03%
EPS Next 3Y6.14%
ACKB.BR Yearly Income VS Free CF VS DividendACKB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B
ACKB.BR Dividend Payout.ACKB.BR Dividend Payout, showing the Payout Ratio.ACKB.BR Dividend Payout.PayoutRetained Earnings

ACKERMANS & VAN HAAREN

EBR:ACKB (8/7/2025, 7:00:00 PM)

220.2

+2.2 (+1.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-29 2025-08-29
Inst Owners12.93%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.30B
Analysts78.46
Price Target237.08 (7.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend3.37
Dividend Growth(5Y)7.81%
DP24.2%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.24%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 15.67
Fwd PE 11.97
P/S 1.21
P/FCF 6.64
P/OCF 5.18
P/B 1.38
P/tB 1.51
EV/EBITDA 14.37
EPS(TTM)14.05
EY6.38%
EPS(NY)18.4
Fwd EY8.35%
FCF(TTM)33.17
FCFY15.07%
OCF(TTM)42.53
OCFY19.31%
SpS182.25
BVpS159.18
TBVpS145.95
PEG (NY)0.62
PEG (5Y)4.6
Profitability
Industry RankSector Rank
ROA 2.27%
ROE 8.71%
ROCE 5.83%
ROIC 4.79%
ROICexc 6.05%
ROICexgc 6.42%
OM 9.41%
PM (TTM) 7.61%
GM 37.01%
FCFM 18.2%
ROA(3y)2.79%
ROA(5y)2.43%
ROE(3y)10.71%
ROE(5y)9.77%
ROIC(3y)3.75%
ROIC(5y)3.25%
ROICexc(3y)3.96%
ROICexc(5y)3.6%
ROICexgc(3y)4.17%
ROICexgc(5y)3.83%
ROCE(3y)4.57%
ROCE(5y)3.96%
ROICexcg growth 3Y2.17%
ROICexcg growth 5Y2.42%
ROICexc growth 3Y3.29%
ROICexc growth 5Y3%
OM growth 3Y6.69%
OM growth 5Y4.48%
PM growth 3Y-6.91%
PM growth 5Y-3.82%
GM growth 3Y0.27%
GM growth 5Y1.41%
F-Score8
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 9.05
Debt/EBITDA 2.54
Cap/Depr 70.44%
Cap/Sales 5.13%
Interest Coverage 8.83
Cash Conversion 139.76%
Profit Quality 239.21%
Current Ratio 0.74
Quick Ratio 0.7
Altman-Z 0.88
F-Score8
WACC4.08%
ROIC/WACC1.17
Cap/Depr(3y)108.72%
Cap/Depr(5y)96.92%
Cap/Sales(3y)8.38%
Cap/Sales(5y)7.72%
Profit Quality(3y)107.38%
Profit Quality(5y)117.68%
High Growth Momentum
Growth
EPS 1Y (TTM)15.83%
EPS 3Y4.64%
EPS 5Y3.4%
EPS Q2Q%13.71%
EPS Next Y25.08%
EPS Next 2Y8.03%
EPS Next 3Y6.14%
EPS Next 5YN/A
Revenue 1Y (TTM)15.74%
Revenue growth 3Y11.91%
Revenue growth 5Y7.19%
Sales Q2Q%13.03%
Revenue Next Year3.92%
Revenue Next 2Y2%
Revenue Next 3Y0.35%
Revenue Next 5YN/A
EBIT growth 1Y34.86%
EBIT growth 3Y19.39%
EBIT growth 5Y11.99%
EBIT Next Year123.1%
EBIT Next 3Y27.9%
EBIT Next 5YN/A
FCF growth 1Y406.47%
FCF growth 3Y33.46%
FCF growth 5Y68.25%
OCF growth 1Y116.56%
OCF growth 3Y21.73%
OCF growth 5Y19.25%